has been cited by the following article(s):
[1]
|
Dopamine, Immunity, and Disease
Pharmacological Reviews,
2023
DOI:10.1124/pharmrev.122.000618
|
|
|
[2]
|
Using novel click chemistry algorithm to design D3R inhibitors as blood–brain barrier permeants
Future Medicinal Chemistry,
2023
DOI:10.4155/fmc-2022-0310
|
|
|
[3]
|
The role of dopamine receptors in lymphocytes and their changes in schizophrenia
Brain, Behavior, & Immunity - Health,
2021
DOI:10.1016/j.bbih.2021.100199
|
|
|
[4]
|
Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment
Journal of Neuroimmune Pharmacology,
2015
DOI:10.1007/s11481-015-9626-9
|
|
|
[5]
|
Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity
Journal of Psychiatric Research,
2012
DOI:10.1016/j.jpsychires.2012.03.004
|
|
|
[6]
|
Comparison of brain and blood gene expression in an animal model of negative symptoms in schizophrenia
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
2012
DOI:10.1016/j.pnpbp.2012.03.003
|
|
|